Renal Inflammation and Fibrosis: A Double-edged Sword

被引:149
作者
Black, Laurence M. [1 ]
Lever, Jeremie M. [1 ]
Agarwal, Anupam [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Nephrol, Nephrol Res & Training Ctr, Rm 647 THT,1720 2nd Ave South, Birmingham, AL 35226 USA
[2] Univ Alabama Birmingham, Dept Vet Affairs, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
acute kidney injury; cellular transdifferentiation; chemokines; chronic kidney disease; cytokines; extracellular matrix; fibrosis; growth factors; transforming growth factor-beta; TISSUE GROWTH-FACTOR; TUBULAR EPITHELIAL-CELLS; ACUTE KIDNEY INJURY; ISCHEMIA-REPERFUSION INJURY; TO-MESENCHYMAL TRANSITION; NECROSIS-FACTOR RECEPTOR; NF-KAPPA-B; TGF-BETA; HEME OXYGENASE-1; UP-REGULATION;
D O I
10.1369/0022155419852932
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Renal tissue injury initiates inflammatory and fibrotic processes that occur to promote regeneration and repair. After renal injury, damaged tissue releases cytokines and chemokines, which stimulate activation and infiltration of inflammatory cells to the kidney. Normal tissue repair processes occur simultaneously with activation of myofibroblasts, collagen deposition, and wound healing responses; however, prolonged activation of pro-inflammatory and pro-fibrotic cell types causes excess extracellular matrix deposition. This review focuses on the physiological and pathophysiological roles of specialized cell types, cytokines/chemokines, and growth factors, and their implications in recovery or exacerbation of acute kidney injury.
引用
收藏
页码:663 / 681
页数:19
相关论文
共 50 条
[21]   VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness [J].
Ndiaye, Papa Diogop ;
Dufies, Maeva ;
Giuliano, Sandy ;
Douguet, Laetitia ;
Grepin, Renaud ;
Durivault, Jerome ;
Lenormand, Philippe ;
Glisse, Natacha ;
Mintcheva, Janita ;
Vouret-Craviari, Valerie ;
Mograbi, Baharia ;
Wurmser, Maud ;
Ambrosetti, Damien ;
Rioux-Leclercq, Nathalie ;
Maire, Pascal ;
Pages, Gilles .
THERANOSTICS, 2019, 9 (03) :661-675
[22]   Nrf2 in cancers: A double-edged sword [J].
Wu, Shijia ;
Lu, Hong ;
Bai, Yongheng .
CANCER MEDICINE, 2019, 8 (05) :2252-2267
[23]   Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy [J].
Kimura, Tomonori ;
Takabatake, Yoshitsugu ;
Takahashi, Atsushi ;
Isaka, Yoshitaka .
CANCER RESEARCH, 2013, 73 (01) :3-7
[24]   Melatonin and inflammation-Story of a double-edged blade [J].
Hardeland, Ruediger .
JOURNAL OF PINEAL RESEARCH, 2018, 65 (04)
[25]   Interleukin 17, the double-edged sword in atherosclerosis [J].
Moeinafshar, Aysan ;
Razi, Sepideh ;
Rezaei, Nima .
IMMUNOBIOLOGY, 2022, 227 (03)
[26]   Collagen as a double-edged sword in tumor progression [J].
Fang, Min ;
Yuan, Jingping ;
Peng, Chunwei ;
Li, Yan .
TUMOR BIOLOGY, 2014, 35 (04) :2871-2882
[27]   Alcohol and the Cardiovascular System: A Double-Edged Sword [J].
Katsiki, Niki ;
Tziomalos, Konstantinos ;
Mikhailidis, Dimitri P. .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) :6276-6288
[28]   Pregnane X receptor: a double-edged sword [J].
Fang Dao-kui ;
Zhang Jian-qing .
CHINESE MEDICAL JOURNAL, 2009, 122 (11) :1333-1341
[29]   Astrocytes: a double-edged sword in neurodegenerative diseases [J].
Ding, Zhi-Bin ;
Song, Li-Juan ;
Wang, Qing ;
Kumar, Gajendra ;
Yan, Yu-Qing ;
Ma, Cun-Gen .
NEURAL REGENERATION RESEARCH, 2021, 16 (09) :1702-1710
[30]   Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease [J].
Xu, Chengfei ;
Liu, Ziling ;
Xiao, Jiangwei .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)